Overexpression of CXCL16 and its receptor CXCR6/Bonzo promotes growth of human schwannomas

GLIA

Volumn 56, Issue 7, 2008, Pages 764-774

  Held Feindt, Janka ^a   Rehmke, Brigitte ^a   Mentlein, Rolf ^b   Hattermann, Kirsten ^b   Knerlich, Friederike ^a   Hugo, Heinz Hermann ^a   Ludwig, Andreas ^c   Mehdorn, H Maximilian ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b UNIVERSITY OF KIEL   (Germany)

^c UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Chemokine; Malignant peripheral nerve sheath tumor; Neurinoma

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; CHEMOKINE RECEPTOR CXCR6; CXCL16 CHEMOKINE; GLIAL FIBRILLARY ACIDIC PROTEIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN S 100; ALPHA CHEMOKINE; CHEMOKINE RECEPTOR; CXCL16 PROTEIN, HUMAN; CXCR6 PROTEIN, HUMAN; SCAVENGER RECEPTOR; VIRUS RECEPTOR;

ADULT; AGED; ARTICLE; CARCINOGENESIS; CELL CULTURE; CELL MIGRATION; CELL PROLIFERATION; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PHOSPHORYLATION; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; METASTASIS POTENTIAL; NERVE SHEATH TUMOR; NEURILEMOMA; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TUMOR LOCALIZATION; VESTIBULOCOCHLEAR NERVE; WESTERN BLOTTING; CELL DIVISION; GENE EXPRESSION REGULATION; GENETICS; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPINAL CORD TUMOR;

CELL DIVISION; CHEMOKINES, CXC; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; IMMUNOHISTOCHEMISTRY; NEURILEMMOMA; RECEPTORS, CHEMOKINE; RECEPTORS, SCAVENGER; RECEPTORS, VIRUS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SPINAL CORD NEOPLASMS;

EID: 47249150273     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.20651     Document Type: Article

References (41)

1. Abel S, Hundhausen C, Mentlein R, Schulte A, Berkhout TA, Broadway N, Hartmann D, Sedlacek R, Dietrich S, Muetze B, Schuster B, Kallen KJ, Saftig P, Rose-John S, Ludwig A. 2004. The transmembrane CXC-chemokine ligand 16 is induced by IFN-gamma and TNF-alpha and shed by the activity of the disintegrin-like metalloproteinase ADAM10. J Immunol 172:6362-6372.
2. Ben-Baruch A. 2006. The multifaceted roles of chemokines in malignancy. Cancer Metastasis Rev 25:357-371.
3. Burger PC, Scheithauer BW. 1994. Tumors of the central nervous system. Atlas of Tumor Pathology, 3rd series, Fascicle 10. Washington, D.C.: Armed Forces Institute of Pathology.
4. i, phosphatidylinositol 3-kinase, Akt, IκB kinase, and nuclear factor-κB and induces cell-cell adhesion and aortic smooth muscle cell proliferation. J Biol Chem 279:3188-3196.
5. Cross M, Dexter TM. 1991. Growth factors in development, transformation, and tumorigenesis. Cell 64:271-280.
6. Ducatman BS, Scheithauer BW, Piepgras DG, Reiman HM. 1986. Malignant peripheral nerve sheath tumor. A clinicopathologic study of 120 cases. Cancer 57:2006-2021.
7. Feindt J, Becker I, Blömer U, Hugo H-H, Mehdorn HM, Krisch B, Mentlein R. 1995. Expression of somatostatin receptor subtypes in cultured astrocytes and gliomas. J Neurochem 65:1997-2005.
8. Ferner RE, O'Doherty MJ. 2002. Neurofibroma and schwannoma. Curr Opin Neurol 15:679-684.
9. Gough PJ, Garton KJ, Wille PT, Rychlewski M, Dempsey PJ, Raines EW. 2004. A disintegrin and metalloproteinase 10-mediated cleavage and shedding regulates the cell surface expression of CXC chemokine ligand 16. J Immunol 172:3678-3685.
10. Greenberg MS. 2006. Handbook of neurosurgery, 6th ed. New York, USA: Thieme Medical Publishers.
11. Halliday AL, Sobel RA, Martuza RL. 1991. Benign spinal nerve sheath tumors: Their occurrence sporadically and in neurofibromatosis types 1 and 2. J Neurosurg 74:248-253.
12. Hanemann CO, Bartelt-Kirbach B, Diebold R, Kamchen K, Langmesser S, Utermark T. 2006. Differential gene expression between human schwannoma and control schwann cells. Neuropathol Appl Neurobiol 32:605-614.
13. Hase K, Murakami T, Takatsu H, Shimaoka T, Iimura M, Hamura K, Kawano K, Ohshima S, Chihara R, Itoh K, Yonehara S, Ohno H. 2006. The membrane-bound chemokine CXCL16 expressed on follicle-associated epithelium and M cells mediates lympho-epithelial interaction in GALT. J Immunol 176:43-51.
14. Held-Feindt J, Dr̈ner L, Sahan G, Mehdorn HM, Mentlein R. 2006. annabinoid receptors in human astroglial tumors. J Neurochem 98:886-893.
15. Hruban RH, Shiu MH, Senie RT, Woodruff JM. 1990. Malignant peripheral nerve sheath tumors of the buttock and lower extremity. A study of 43 cases. Cancer 66:1253-1265.
16. Kakinuma T, Hwang ST. 2006. Chemokines, chemokine receptors, and cancer metastasis. J Leukoc Biol 79:639-651.
17. Kim CH, Kunkel EJ, Boisvert J, Johnston B, Campbell JJ, Genovese MC, Greenberg HB, Butcher EC. 2001. Bonzo/CXCR6 expression defines type 1-polarized T-cell subsets with extralymphoid tissue homing potential. J Clin Invest 107:595-601.
18. le Blanc LMP, van Lieshout AWT, Adema GJ, van Riel PLCM, Verbeek MM, Radstake TRDJ. 2006. CXCL16 is elevated in the cerebrospinal fluid versus serum in inflammatory conditions with suspected and proved central nervous system involvement. Neurosci Lett 397:145-148.
19. Lewis JJ, Brennan MR. 1996. Soft tissue sarcomas. Curr Probl Surg 33:817-872.
20. Lu H, Ouyang W, Huang C. 2006. Inflammation, a key event in cancer development. Mol Cancer Res 4:221-233.
21. Ludwig A, Schulte A, Schnack C, Hundhausen C, Reiss K, Brodway N, Held-Feindt J, Mentlein R. 2005. Enhanced expression and shedding of the transmembrane chemokine CXCL16 by reactive astrocytes and glioma cells. J Neurochem 9:1293-1303.
22. Matloubian M, David A, Engel S, Ryan JE, Cyster JG. 2000. A transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo. Nat Immunol 1:298-304.
23. Mentlein R, Held-Feindt J. 2002. Pleiotrophin, an angiogenic and mitogenic growth factor, is expressed in human gliomas. J Neurochem 83:747-753.
24. Mori K, Chano T, Yamamoto K, Matsusue Y, Okabe H. 2004. Expression of macrophage inflammatory protein-1 alpha in Schwann cell tumors. Neuropathology 24:131-135.
25. Moskopp D, Wassmann H. 2005. Neurosurgery. Stuttgart, Germany: Schatthauer GmbH.
26. Mrugala MM, Batchelor TT, Plotkin SR. 2005. Peripheral and cranial nerve sheath tumors. Curr Opin Neurol 18:604-610.
27. Nakayama T, Hieshima K, Izawa D, Tatsumi Y, Kanamaru A, Yoshie O. 2003. Cutting edge: Profile of chemokine receptor expression on human plasma cells accounts for their efficient recruitment to target tissues. J Immunol 170:1136-1140.
28. Rangwala R, Banine F, Borg J-P, Sherman LS. 2005. Erbin regulates mitogen-activated protein (MAP) kinase activation and MAP kinase-dependent interactions between merlin and adherens junction complexes in Schwann cells. J Biol Chem 280:11700-11797.
29. Ricci A Jr, Parham DW, Woodruff JM, Callihan T, Green A, Erlandson RA. 1984. Malignant peripheral nerve sheath tumors arising from ganglioneuromas. Am J Surg Pathol 8:19-29.
30. Sakaguchi N, Sano K, Makato I, Baba T, Fukuzawa M, Hotchi M. 1996. A case of von Recklinghausen!s disease with bilateral pheochromocytoma-malignant peripheral nerve sheath tumors of the adrenal and gastrointestinal autonomic nerve tumors. Am J Surg Pathol 20:889-897.
31. Salvati M, Ciapetta P, Raco A, Capone R, Artico M, Santoro A. 1992. Radiation-induced schwannomas of the neuroaxis. Report of three cases. Tumori 78:143-146.
32. Scheithauer BW, Woodruff JM, Erlandson R. 1997. Tumors of the peripheral nervous system. Atlas of tumor pathology, 3rd series, Fascicle 24. Washington, D.C.: Armed Forces Institute of Pathology.
33. Shimaoka T, Kume N, Minami M, Hayashida K, Kataoka H, Kita T, Yonehara S. 2000. Molecular cloning of a novel scavenger receptor for oxidized low density lipoprotein, SR-PSOX, on macrophages. J Biol Chem 275:40663-40666.
34. Shimaoka T, Nakayama T, Fukumoto N, Kume N, Takahashi S, Yamaguchi J, Minami M, Hayashida K, Kita T, Ohsumi J, Yoshie O, Yonehara S. 2004. Cell surface-anchored SR-PSOX/CXC chemokine ligand 16 mediates firm adhesion of CXC chemokine receptor 6-expressing cells. J Leukoc Biol 75:267-274.
35. Tofaris GK, Patterson PH, Jessen KR, Mirsky R. 2002. Denervated Schwann cells attract monocytes by secretion of leukemia inhibitory factor (LIF) and monocyte chemoattractant protein-1 in a process regulated by interleukin-6 and LIF. J Neurosci 22:6696-6703.
36. Tong Y, Mentlein R, Buhl R, Hugo H-H, Mehdorn HM, Held-Feindt J. 2007. Overexpression of midkine contributes to anti-apoptotic effects in human meningiomas. J Neurochem 100:1097-1107.
37. Utermark T, Kaempchen K, Antoniadis G, Hanemann CO. 2005. Reduced apoptosis rates in human schwannomas. Brain Pathol 15:17-22.
38. van der Voort R, van Lieshout AW, Toonen LW, Sloetjes AW, van den Berg WB, Figdor CG, Radstake TR, Adema GJ. 2005. Elevated CXCL16 expression by synovial macrophages recruits memory T cells into rheumatoid joints. Arthritis Rheum 52:1381-91.
39. Wågstäter D, Hugander A, Dimberg J. 2004. Expression of CXCL16 in human rectal cancer. Int J Mol Med 14:65-69.
40. Woodruff JM, Selig AM, Crowley K, Allen PW. 1994. Schwannoma with malignant transformation. A rare, distinctive peripheral nerve tumor. Am J Surg Pathol 18:882-895.
41. Zlotnik A. 2006. Chemokines and cancer. Int J Cancer 119:2026-2029.